financetom
Business
financetom
/
Business
/
Electronic Arts Shares Soar On Potential Deal, Upcoming Battlefield 6 Release
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Electronic Arts Shares Soar On Potential Deal, Upcoming Battlefield 6 Release
Sep 29, 2025 10:12 AM

Wedbush analyst Alicia Reese downgraded Electronic Arts Inc ( EA ) from Outperform to Neutral and lowered her price target from $210 to $200.

The downgrade comes on the heels of Wall Street Journal report that the video game company was preparing a take-private deal valued at up to $50 billion.

Reese also cut the price target from $210 to $200.

The Electronic Arts Thesis: The upcoming release of Battlefield 6 has driven the company's shares higher over the past few months, Reese said in the downgrade note.

Check out other analyst stock ratings.

"FY:26 is proving to be a pivotal year for EA, with Battlefield likely to drive outsized growth and margin expansion through FY:27, building on a solid foundation of recurring revenue from its various evergreen sports titles and other properties," the analyst wrote.

There is room for Electronic Arts ( EA ) to grow its mobile revenues, where a private takeover could "create meaningful value," she stated.

If the deal does not go through, the company is likely to report at least 8% revenue growth this fiscal year with earnings accretion from share repurchases, Reese further said.

EA Price Action: Shares of Electronic Arts ( EA ) had risen by 4.83% to $202.69 at the time of publication on Monday.

Read More:

Intel, Marvell, Electronic Arts Are Among The Top 10 Large-Cap Gainers Last Week (Sep. 22 – Sep. 26): Are The Others In Your Portfolio?

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UK takes aim at social media over dangerous knife sales
UK takes aim at social media over dangerous knife sales
Nov 13, 2024
LONDON, Nov 13 (Reuters) - Britain said the bosses of social media companies and online marketplaces could be personally fined if they fail to tackle the sale and promotion of dangerous and illegal knives on their platforms, under proposals published on Wednesday. Interior minister Yvette Cooper said an epidemic of knife crime was devastating families and communities across the country,...
Spirit Airlines Reportedly Considering Bankruptcy Protection After Frontier Deal Fails
Spirit Airlines Reportedly Considering Bankruptcy Protection After Frontier Deal Fails
Nov 13, 2024
07:28 AM EST, 11/13/2024 (MT Newswires) -- Spirit Airlines ( SAVE ) may seek bankruptcy protection after merger discussions with Frontier Group Holdings ( ULCC ) fell apart, multiple media reports said late Tuesday. Spirit said in its filing late Tuesday that it was unable to submit its Q3 earnings report, citing efforts to restructure obligations have diverted time and...
Trump Media & Technology Group Insider Sold Shares Worth $3,844,446, According to a Recent SEC Filing
Trump Media & Technology Group Insider Sold Shares Worth $3,844,446, According to a Recent SEC Filing
Nov 13, 2024
03:21 AM EST, 11/13/2024 (MT Newswires) -- Eric Swider, Director, on November 08, 2024, sold 136,183 shares in Trump Media & Technology Group ( DJT ) for $3,844,446. Following the Form 4 filing with the SEC, Swider has control over a total of 18,043 shares of the company, with 18,043 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1849635/000147450624000238/xslF345X05/primary_doc.xml Price: 30.08, Change: -0.39, Percent...
BioNTech buys China's Biotheus to support oncology strategy
BioNTech buys China's Biotheus to support oncology strategy
Nov 13, 2024
Nov 13 (Reuters) - German drugmaker BioNTech has agreed to acquire Chinese biotech company Biotheus to support its oncology strategy and gain full global rights to the bispecific antibody candidate BNT327, it said on Wednesday. BNT327 has been tested in clinical trials with tumour patients, and Biotheus previously held the rights to commercialize it in the Greater China market. Under...
Copyright 2023-2026 - www.financetom.com All Rights Reserved